IASO BIOMED, INC. - Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Cash Flows from Operating Activities:
Net Loss	$ (716,413)	$ (610,650)
Adjustments to reconcile net loss to net cash used in operating activities:
Issuance of stock for license fees		285,263
Share-based compensation	224,446	0
Contributed services	5,000	30,000
Changes in assets and liabilities:
Prepaid expenses, increase decrease	(170)	(1,393)
Accounts payable, increase decrease	35,631	(3,539)
Accrued salaries, increase decrease	187,500
Accrued interest, related party, increase decrease	2,006	197
Net cash used in operating activities	(262,000)	(300,122)
Cash Flows from Financing Activities:
Proceeds from issuance of notes payable, related party	53,000	25,000
Payments on notes payable, related party	(18,000)
Proceeds from the sale of common stock	231,500	175,000
Proceeds from the exercise of warrants	2,500
Net cash provided by financing activities	269,000	200,000
Net Increase (Decrease) in Cash	7,000	(100,122)
Cash, beginning of period	13,191	113,313
Cash, end of period	20,191	$ 13,191
Supplemental Cash Flow Information
Cash paid for interest, note payable - officer	$ 3